Cg Oncology, Inc.
Clinical trials sponsored by Cg Oncology, Inc., explained in plain language.
-
New hope for bladder cancer patients unresponsive to standard therapy
Disease control AVAILABLEThis program provides access to an experimental treatment called cretostimogene grenadenorepvec for people with a type of bladder cancer that has not responded to standard therapy. It is for patients with non-muscle invasive bladder cancer that includes carcinoma in situ. The goa…
Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated May 26, 2026 07:23 UTC
-
New bladder cancer drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests a drug called cretostimogene grenadenorepvec in 325 people with high-risk non-muscle-invasive bladder cancer. The goal is to see if it can make tumors disappear or keep them from coming back. Participants have either not received prior treatment or have had prior…
Phase: PHASE2 • Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated May 26, 2026 07:19 UTC